Can MiBoFlo effectively liquefy meibomian gland secretions?

Yes. More than a decade of published clinical research supports the use of controlled therapeutic heat to liquefy obstructed meibomian gland secretions. MiBoFlo delivers consistent thermoelectric heat that softens inspissated meibum, facilitating gland expression and supporting restoration of a healthier tear film in patients with Meibomian Gland Dysfunction (MGD).

Is MiBoFlo comparable to a warm compress?

No. While warm compresses remain a useful home therapy, they cannot consistently deliver or maintain therapeutic temperatures. They cool rapidly after application, making effective gland warming difficult. If overheated, they may irritate the delicate eyelid skin. If too cool, they provide little therapeutic benefit.

MiBoFlo was engineered to overcome these limitations. Using thermoelectric (Peltier) technology, it delivers a controlled temperature of approximately 108°F (42°C) through a medical-grade .925 silver treatment pad and ultrasound gel, providing efficient and consistent heat transfer throughout the treatment. This controlled delivery offers greater precision and repeatability than conventional warm compresses while complementing an overall dry eye treatment program.

Is treating from the inner eyelid more effective?

The meibomian glands lie within the tarsal plate, adjacent to the palpebral conjunctiva. MiBoFlo’s thermoelectric system generates sufficient thermal energy to warm the glands through the eyelid tissues without requiring internal heat application. Real-time temperature measurements have demonstrated that therapeutic tissue temperatures are achieved during treatment, allowing heat to reach the target glands safely and effectively.

Can MiBoFlo treat the upper and lower eyelids simultaneously?

Yes. MiBoFlo features sterilizable, interchangeable treatment pads powered by a high-capacity thermal engine. This design allows clinicians to efficiently treat both the upper and lower eyelids during the same session. Most bilateral treatments are completed in approximately 20 minutes, making the procedure both efficient and comfortable for patients.

Why are multiple MiBoFlo treatments recommended?

MGD is a chronic, progressive disease rather than a one-time obstruction. Restoring gland function requires more than simply expressing stagnant meibum. Repeated thermal therapy helps normalize meibum quality, improve gland performance, and stabilize the tear film over time.

This treatment philosophy is supported by more than 10 years of published clinical research, with studies consistently demonstrating improvements in both patient symptoms and objective clinical signs. As with most chronic ocular surface diseases, periodic maintenance treatments help preserve long-term results and support ongoing ocular surface health.

What Is the Most Effective Treatment Strategy for MGD?

Dry eye disease is multifactorial, making combination therapy the most effective approach for many patients. While MiBoFlo has over a decade of published clinical research supporting its effectiveness in treating Meibomian Gland Dysfunction (MGD), clinical outcomes can often be enhanced when it is integrated into a comprehensive treatment plan.

This philosophy is the foundation of the Dry Eye Trifecta, a multimodal protocol combining Legacy Wave IPL, MiBoFlo, and EyeLeviate Low-Level Light Therapy (LLLT) to address inflammation, meibomian gland dysfunction, and ocular surface health simultaneously.

Clinical evidence supports this approach. At the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, investigators reported that:

• IPL + MiBoFlo reduced dry eye symptom scores by approximately 40%.
• Radiofrequency + MiBoFlo reduced symptom scores by approximately 33%.
• The greatest improvement occurred after the third treatment, highlighting the value of a structured treatment protocol.
• The findings support MiBoFlo as an integral component of multimodal Dry Eye Spa therapy.

For additional peer-reviewed studies and conference presentations, visit the Article section of the MiBoFlo website. To learn more about implementing the Dry Eye Trifecta, visit DEG Medical.

1. Why doesn’t the heating pad feel hot?
   This is a common question asked about Far Infrared (FIR) technology. This is due to the way the heat is effecting the skin. Standard heating pads and hot compresses heat more of the surface where FIR heats deeper into the tissue. Standard heating pads heat penetration is 2-3mm  and FIR is up to 5cm.
2. Is Far Infrared safe?
   Infrared rays are a part of the Sun’s invisible spectrum. It can’t be seen but it can be felt as heat. They can’t burn you and 100% safe for all living things. FIR heating pads do not emit UV radiation at all. Regular heating pads produce dangerous EMF radiation.
3. Why is Far Infrared helpful for Dry Eye?
   While an electric heating pad has no other health benefits other than temporarily heating of the skin, the Journal of American Medical has published a list of the heat benefits of far infrared therapy. For Dry Eye these are increasing of blood circulation, helping remove toxins in the body, and promotes stress relief and relaxation.